- Abstract submission is CLOSED.
- Notification Date January 15 (Fri), 2021
* All accepted submissions will be shared at online presentation sessions.
Acute Coronary Syndromes (STEMI, NSTE-ACS)
Adjunctive Procedures (Thrombectomy, Atherectomy, Special Balloons)
Bifurcation/Left Main Diseases and Intervention
Cardiac Surgery/Hybrid Revascularization
Chronic Total Occlusion
Complex and Higher Risk Procedures for Indicated Patients (CHIP)
Hemodynamic Support and Cardiogenic Shock
Stents (Bare-metal, Drug-eluting)
Aorta Disease and Intervention
Carotid & Neurovascular Intervention
Hypertension Therapies and Renal Denervation
Peripheral Vascular Disease and Intervention
IMAGING AND PHYSIOLOGIC LESION ASSESSMENT
Physiologic Lesion Assessment
STRUCTURAL HEART DISEASE
Congenital Heart Disease (ASD, PDA, PFO, VSD)
Hypertrophic Obstructive Cardiomyopathy
Left Atrial Appendage Closure
Pulmonary Intervention: CTEPH, PHTN
Valvular Intervention: Aortic
Valvular Intervention: Mitral or Tricuspid
Others (Structural Heart Disease)
Basic Science, Animal Models and Preclinical Studies
Cell Therapy and Angiogenesis
Innovative Devices and Futuristic Therapies
Quality, Guidelines and Appropriateness Criteria
Renal Insufficiency and Contrast Nephropathy
Vascular Access (Transradial)
Women¡¯s Health Issues
Publication in the Journal of the American College of Cardiology (JACC)
Accepted abstracts will be published in an online supplement issue of "The Journal of the American College of Cardiology(JACC)".
Advantages for TCTAP Best Young Scientist Award
Presenters will get advantages when they apply for the Best Young Scientist Award of TCTAP 2022.
Cash Rewards for Late-Breaking Clinical Trials (LBCT) Acceptances
Case rewards will be given to the abstracts presented in the LBCT session.
If you have any questions, please feel free to contact us at email@example.com.